These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9436925)

  • 1. Differential gene expression of the neural cell adhesion molecule (N-CAM) in a panel of multiple myeloma cell lines.
    De Greef C; Van Riet I; Bakkus MH; Van Camp B
    Leukemia; 1998 Jan; 12(1):86-93. PubMed ID: 9436925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells.
    Van Riet I; De Waele M; Remels L; Lacor P; Schots R; Van Camp B
    Br J Haematol; 1991 Nov; 79(3):421-7. PubMed ID: 1721526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells.
    Barker HF; Hamilton MS; Ball J; Drew M; Franklin IM
    Br J Haematol; 1992 Jul; 81(3):331-5. PubMed ID: 1382543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the neural cell adhesion molecule (CD56) by human myeloma cells.
    Drach J; Gattringer C; Huber H
    Clin Exp Immunol; 1991 Mar; 83(3):418-22. PubMed ID: 1706237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neural cell adhesion molecule NCAM in multiple myeloma.
    Kaiser U; Auerbach B; Oldenburg M
    Leuk Lymphoma; 1996 Feb; 20(5-6):389-95. PubMed ID: 8833394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene regulation of cell adhesion: a key step in neural morphogenesis.
    Edelman GM; Jones FS
    Brain Res Brain Res Rev; 1998 May; 26(2-3):337-52. PubMed ID: 9651550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the CD56 promoter and its association with proliferation, anti-apoptosis and clinical factors in multiple myeloma.
    Damgaard T; Knudsen LM; Dahl IM; Gimsing P; Lodahl M; Rasmussen T
    Leuk Lymphoma; 2009 Feb; 50(2):236-46. PubMed ID: 19235015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myeloma.
    Yoshida T; Ri M; Kinoshita S; Narita T; Totani H; Ashour R; Ito A; Kusumoto S; Ishida T; Komatsu H; Iida S
    PLoS One; 2018; 13(5):e0196780. PubMed ID: 29738534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD56 expression in human myeloma cells derived from the neurogenic gene expression: possible role of the SRY-HMG box gene, SOX4.
    Iqbal MS; Otsuyama K; Shamsasenjan K; Asaoku H; Kawano MM
    Int J Hematol; 2010 Mar; 91(2):267-75. PubMed ID: 20049565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric modulation of AMPA-type glutamate receptors increases activity of the promoter for the neural cell adhesion molecule, N-CAM.
    Holst BD; Vanderklish PW; Krushel LA; Zhou W; Langdon RB; McWhirter JR; Edelman GM; Crossin KL
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2597-602. PubMed ID: 9482932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-MAF oncogene dysregulation in multiple myeloma: frequency and biological relevance.
    Rasmussen T; Knudsen LM; Dahl IM; Johnsen HE
    Leuk Lymphoma; 2003 Oct; 44(10):1761-6. PubMed ID: 14692531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56).
    Lanier LL; Chang C; Azuma M; Ruitenberg JJ; Hemperly JJ; Phillips JH
    J Immunol; 1991 Jun; 146(12):4421-6. PubMed ID: 1710251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD56/N-CAM antigen and some other adhesion molecules in various human endocrine glands.
    Zeromski J; Lawniczak M; Galbas K; Jenek R; Golusiński P
    Folia Histochem Cytobiol; 1998; 36(3):119-25. PubMed ID: 9773295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cells.
    Tassone P; Gozzini A; Goldmacher V; Shammas MA; Whiteman KR; Carrasco DR; Li C; Allam CK; Venuta S; Anderson KC; Munshi NC
    Cancer Res; 2004 Jul; 64(13):4629-36. PubMed ID: 15231675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
    Martín P; Santón A; Bellas C
    Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding and transcriptional activation of the promoter for the neural cell adhesion molecule by HoxC6 (Hox-3.3).
    Jones FS; Holst BD; Minowa O; De Robertis EM; Edelman GM
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6557-61. PubMed ID: 8393570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adhesive interactions between tumour cells and bone marrow stromal elements in human multiple myeloma.
    Faid L; Van Riet I; De Waele M; Facon T; Schots R; Lacor P; Van Camp B
    Eur J Haematol; 1996 Nov; 57(5):349-58. PubMed ID: 9003475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPAN-Xb expression in myeloma cells is dependent on promoter hypomethylation and can be upregulated pharmacologically.
    Wang Z; Zhang J; Zhang Y; Lim SH
    Int J Cancer; 2006 Mar; 118(6):1436-44. PubMed ID: 16187275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma.
    Misiewicz-Krzeminska I; Sarasquete ME; Vicente-Dueñas C; Krzeminski P; Wiktorska K; Corchete LA; Quwaider D; Rojas EA; Corral R; Martín AA; Escalante F; Bárez A; García JL; Sánchez-García I; García-Sanz R; San Miguel JF; Gutiérrez NC
    Clin Cancer Res; 2016 Jan; 22(1):207-17. PubMed ID: 26341922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
    Anisowicz A; Sotiropoulou G; Sager R
    Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.